Light-Activated dye could save sight from severe eye infections
NCT ID NCT06271772
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a light-activated dye called rose Bengal, combined with antibiotics and steroids, can improve vision in people with severe bacterial eye infections. About 60 adults with corneal ulcers and vision loss will receive either the dye treatment or a sham procedure. The goal is to see if the dye helps reduce scarring and leads to better eyesight after six months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Rose Bengal (a dye) activated by green light, plus antibiotic and steroid eye drops
What this could lead to
If it works, this could offer a new way to treat severe bacterial eye infections, potentially improving vision and reducing scarring.
What could go wrong
This is a small, early feasibility study with only 60 participants. The treatment adds complexity and may not provide significant benefit over standard care. Risks include eye irritation or worsening infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL KERATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aravind Eye Care System
Madurai, Tamil Nadu, India
-
Federal University of São Paulo
São Paulo, Brazil